A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
NCT07606066 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2026-05-26
Summary
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.
Conditions
Interventions
- OTHER
-
Procedure: assessment
The approximate volume of blood required is 2 mL
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-06
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
Countries
- United States
- Brazil
- China
- Malaysia
- Poland
- Turkey (Türkiye)
Study Locations
More Related Trials
-
An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes
NCT03786406 ·Status: COMPLETED
-
Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients
NCT01103609 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes
NCT02597101 ·Status: COMPLETED ·Phase: PHASE2
-
Subjects With T2D or at Risk of T2D Cohort Follow-up
NCT05567692 ·Status: SUSPENDED
-
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan
NCT02226822 ·Status: COMPLETED
-
Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes
NCT02946632 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
NCT02616666 ·Status: COMPLETED ·Phase: PHASE4
-
Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus
NCT04744636 ·Status: COMPLETED ·Phase: PHASE1
-
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
NCT00663260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus
NCT01906294 ·Status: TERMINATED
-
Using of SGLt2 Inhibitors in Patients With Type 2 DM
NCT06268977 ·Status: NOT_YET_RECRUITING
-
The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.
NCT06719661 ·Status: COMPLETED ·Phase: NA
-
Observational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine Disorders
NCT07206875 ·Status: NOT_YET_RECRUITING
-
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
NCT06851962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Dapagliflozin in Type 2 Diabetes Patients, a Retrospective Cohort Study From Turkey
NCT03407196 ·Status: COMPLETED
-
AI Ready and Exploratory Atlas for Diabetes Insights
NCT06002048 ·Status: ENROLLING_BY_INVITATION
-
Effect of Anti-diabetic Drugs on Glycemic Variability
NCT02925559 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM)
NCT00960791 ·Status: COMPLETED ·Phase: PHASE1
-
A Study In Patients With Type 2 Diabetes Mellitus
NCT00256867 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus
NCT02426541 ·Status: COMPLETED ·Phase: PHASE4
-
A Real World Experience of Dapagliflozin in Type 2 Diabetes
NCT02966626 ·Status: COMPLETED
-
The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
NCT06611904 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk
NCT05214573 ·Status: COMPLETED
-
A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients
NCT01221519 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes
NCT01006590 ·Status: COMPLETED ·Phase: PHASE4